Regulators, marketers seek to clarify pharma's marketing role on social media at hearings

Share this article:

Federal regulators and pharmaceutical company marketers sought to clear up regulations for online and social media marketing strategies at the Food and Drug Administration's November 12 hearings on the topic.

The testimony addressed four questions: for what online communications should manufacturers, packagers or distributors be accountable; how companies can fulfill regulatory requirements on the Internet and social media in light of space limitations and real-time tools; what parameters should apply to the posting of corrective information on sites controlled by third parties; and when the use of links is appropriate.

Executives from J&J and Sanofi-Aventis offered specific thoughts on where the FDA could allow links, corporate responsibility for content and what might constitute adequate provision of risk information within space-limited formats like Twitter.

Click here to read Medical Marketing and Media's full coverage of the hearings.

Share this article:
You must be a registered member of Direct Marketing News to post a comment.
close

Next Article in Digital Marketing

Follow us on Twitter @dmnews

Latest Jobs:

Featured Listings

More in Digital Marketing

IAB Tech Lab to Set Global Digital Marketing Standards

IAB Tech Lab to Set Global Digital Marketing ...

In looking to solve complex tech issues, the association opens up full membership to agencies and solutions providers.

Integration Meets Innovation in Planters' Digital Campaign

Integration Meets Innovation in Planters' Digital Campaign

The snacks brand found a healthy way to navigate today's world of digital marketing saturation.

USA Today Decides to Play Games for Real

USA Today Decides to Play Games for Real

It partners with game-maker Arkadium to add 60 new digital games to its site, offering advertisers more segmented breakdowns of players.